Bank of America Global Healthcare Conference 2026 May 12, 2026 6:00 PM EDTCompany ParticipantsRoland Sackers - CFO, MD & Member ...
Discusses Strategic Priorities and Latest Developments for QuantiFERON and Latent Tuberculosis Testing May 7, 2026 9:30 AM ...
The law firm of Kirby McInerney LLP is investigating potential claims against Qiagen N.V. ("Qiagen" or the "Company") (NYSE:QGEN). The investigation concerns whether the Company a ...
Thank you, Dominica, and good morning, good afternoon, good evening, to all of you. Thanks again for your attention and interest in Qiagen N.V. A year ago, and I hope and I think that most of you ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 55 cents per share. The diagnostic products maker posted revenue of $492.3 million in the period, which ...
As announced April 27, net sales for Q1 2026 rose 2% on a reported basis to $492 million, while sales at constant exchange rates (CER) were down 1%, compared with the outlook for at least 1% CER ...
Fintel reports that on April 29, 2026, Baird upgraded their outlook for Qiagen N.V. (NYSE:QGEN) from Neutral to Outperform. Analyst Price Forecast Suggests 59.95% Upside As of April 27, 2026, the ...
Co-founder and former CEO Dr. Metin Colpan to become Honorary Chairman of the Supervisory Board after deciding not to stand ...
May 6, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Qiagen N.V. ("Qiagen N.V.") (NYSE: QGEN) concerning potential violations of the federal securities laws.
April 30, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Qiagen N.V. ("Qiagen N.V.") (NYSE: QGEN) concerning potential violations of the federal securities ...
Qiagen NV (NYSE:QGEN) is one of the 10 Stocks Reeling From Huge Losses. Shares of Qiagen nosedived to a seven-year low on Tuesday, slashing 10.7 percent to close at $34.02 apiece, as investors soured ...